Nuvectis Pharma, Inc. (NVCT)

NCM – Real Time Price. Currency in USD

19.55

+0.14 (0.72%)

Market open: Aug 12, 2026, 12:21 PM EDT

19.41

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

04.08.2026

Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights

FORT LEE, N.J., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative therapies for the treatment of complement-related conditions and oncology, today reported its financial results for the second quarter of 2026 and provided an update on recent business progress.

Videos

No Data

There is no data to display

Press releases

04.08.2026

Nuvectis Pharma, Inc. (NVCT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Nuvectis Pharma, Inc. (NVCT)

Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights

Videos

No Data

Press releases

Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights

Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights

Videos

No Data

Press releases

Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights

Search stocks

Nuvectis Pharma, Inc. (NVCT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Nuvectis Pharma, Inc. (NVCT)

Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights

Videos

No Data

Press releases

Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights

Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights

Videos

No Data

Press releases

Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights